TUMOUR MARKER INCREASED

This adverse event was reported 4803 times

These drugs are most commonly taken by patients reporting TUMOUR MARKER INCREASED:

# Drug Count
0 PALBOCICLIB 876
1 FULVESTRANT 675
2 LETROZOLE 569
3 LETROZOLE TABLETS 420
4 NIRAPARIB 359
5 CAPECITABINE 351
6 RIBOCICLIB 350
7 EVEROLIMUS 267
8 EXEMESTANE 262
9 DENOSUMAB 257
See all common drugs associated with TUMOUR MARKER INCREASED

TUMOUR MARKER INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ELACESTRANT 230 0.0320
1 TRASTUZUMAB-QYYP 11 0.0282
2 FULVESTRANT 675 0.0201
3 NIRAPARIB 359 0.0162
4 EXEMESTANE 262 0.0122
5 RIBOCICLIB 350 0.0107
6 PALBOCICLIB 876 0.0092
7 LETROZOLE 569 0.0091
8 OLAPARIB 185 0.0086
9 LETROZOLE TABLETS 420 0.0086
See all drugs enriched for association with TUMOUR MARKER INCREASED